Do you know why programmed death-ligand 1 (PD-L1) testing and targeted therapy are so important for improving patient care?

Credit available for this activity expires: 6/27/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002597?ecd=bdc_podcast_libsyn_mscpedu

How ready are you to optimally manage subcutaneous immunotherapy in your practice?

Credit available for this activity expires: 6/25/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002630?ecd=bdc_podcast_libsyn_mscpedu

Are you up to date with management strategies for early breast cancer?    Credit available for this activity expires: 06/03/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002593?ecd=bdc_podcast_libsyn_mscpedu

What are the key challenges that women with multiple sclerosis (MS) face during their pregnancy journey?

Credit available for this activity expires: 4/30/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002489?ecd=bdc_podcast_libsyn_mscpedu

Did you know that there are several approved tumor agnostic therapies? Join our experts for an in-depth discussion.

Credit available for this activity expires: 04/30/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/advancing-precision-oncology-recent-progress-and-future-2025a1000a6b?ecd=bdc_podcast_libsyn_mscpedu

Do you know the latest strategies to optimize care for HER2-positive gastric and gastroesophageal junction (GEJ) cancers?   Credit available for this activity expires: 4/30/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002494?ecd=bdc_podcast_libsyn_mscpedu

Did you know that tumor area positivity (TAP) scoring can be completed up to 6 times faster than combined positive score (CPS)?   Credit available for this activity expires: 4/23/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002476?ecd=bdc_podcast_libsyn_mscpedu

Do you know how important treatment convenience and quality of life are to patients when selecting paroxysmal nocturnal hemoglobinuria (PHN) therapy?

Credit available for this activity expires: 3/31/2026 Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002332?ecd=bdc_podcast_libsyn_mscpedu

Eight answers to help you do better for these patients.

Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002029?ecd=bdc_podcast_libsyn_mscpedu